Sulindac is a long-acting nonsteroidal anti-inflammatory drug (NSAID) widely used for the
management of osteoarthritis, rheumatoid arthritis, ankylosing sponydlitis, and acute gouty arthritis.
Reports of sulindac toxicity in the literature are rare. We report the case of a 22-year old male with a
history of bipolar disorder who was brought to the emergency department after ingesting
approximately 15 g of sulindac in a suicide attempt. He was found to have acute kidney injury and hyperbilirubinemia.
Despite aggressive fluid resuscitation, his renal function progressively worsened requiring the initiation of hemodialysis.
Ten days following ingestion of sulindac, he began to develop ischemic skin changes with a gangrenous appearance in his
hands and feet. He continued to receive supportive treatment, and his acute kidney injury, hyperbillirubinemia, and
ischemic skin necrosis eventually resolved. Clinicians should be aware of this long-acting NSAID and its ability to cause
prolonged multisystem organ dysfunction.